ATE43583T1 - Quinolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel. - Google Patents
Quinolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel.Info
- Publication number
- ATE43583T1 ATE43583T1 AT85400004T AT85400004T ATE43583T1 AT E43583 T1 ATE43583 T1 AT E43583T1 AT 85400004 T AT85400004 T AT 85400004T AT 85400004 T AT85400004 T AT 85400004T AT E43583 T1 ATE43583 T1 AT E43583T1
- Authority
- AT
- Austria
- Prior art keywords
- phenyl
- alkyl
- image
- alkoxy
- hydrogen
- Prior art date
Links
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005059 halophenyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 208000018875 hypoxemia Diseases 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- -1 trifluoromethylphenyl Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8400058A FR2557570B1 (fr) | 1984-01-04 | 1984-01-04 | Nouveaux derives de la quinoleine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
| EP85400004A EP0148167B1 (de) | 1984-01-04 | 1985-01-04 | Quinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE43583T1 true ATE43583T1 (de) | 1989-06-15 |
Family
ID=9299814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85400004T ATE43583T1 (de) | 1984-01-04 | 1985-01-04 | Quinolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4629728A (de) |
| EP (1) | EP0148167B1 (de) |
| JP (1) | JPS60248673A (de) |
| AT (1) | ATE43583T1 (de) |
| AU (1) | AU569208B2 (de) |
| CA (1) | CA1228359A (de) |
| DE (1) | DE3570658D1 (de) |
| ES (1) | ES8605796A1 (de) |
| FR (1) | FR2557570B1 (de) |
| GR (1) | GR850033B (de) |
| IE (1) | IE57934B1 (de) |
| NZ (1) | NZ210762A (de) |
| OA (1) | OA07926A (de) |
| PT (1) | PT79795B (de) |
| ZA (1) | ZA8594B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116827A (en) * | 1986-10-23 | 1992-05-26 | American Cyanamid Company | Quinolinecarboxylic acid derivatives as solubilized pro-drugs |
| US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| SE9103745D0 (sv) * | 1991-12-18 | 1991-12-18 | Wikstroem Haakan | Aryl-triflates and related compounds |
| IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| GB9602166D0 (en) * | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US6313127B1 (en) * | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
| UA56197C2 (uk) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| JP2001511798A (ja) | 1997-02-13 | 2001-08-14 | ゼネカ・リミテッド | オキシド−スクアレンシクラーゼ抑制剤として有用な複素環化合物 |
| AU5999798A (en) | 1997-02-13 | 1998-09-08 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
| US20150025085A1 (en) * | 2012-01-31 | 2015-01-22 | Varinel Inc. | Iron Chelators And Uses Thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL148312B (nl) * | 1965-03-10 | 1976-01-15 | Pfizer | Werkwijze voor het bereiden van een geneesmiddel dat een of een aantal 1-chinolyl-2-alkylaminoethanolderivaten en/of de zuuradditiezouten daarvan bevat en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen, alsmede werkwijze voor het bereiden van deze geneeskrachtige derivaten en de zuuradditiezouten daarvan. |
| US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
| GB1369379A (en) * | 1972-04-07 | 1974-10-09 | Science Union & Cie | Benzodioxole derivatives and processes for preparing them |
| DE2818423A1 (de) * | 1978-04-27 | 1979-11-08 | Hoechst Ag | Neue isochinolinderivate und verfahren zu ihrer herstellung |
| DE3034001A1 (de) * | 1980-09-10 | 1982-04-22 | Hoechst Ag, 6000 Frankfurt | Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung |
| HU190796B (en) * | 1981-06-12 | 1986-11-28 | Roussel Uclaf,Fr | Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives |
| AU532361B2 (en) * | 1981-09-01 | 1983-09-29 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| FR2519986A1 (fr) * | 1982-01-21 | 1983-07-22 | Adir | Nouveaux derives de benzodioxine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
-
1984
- 1984-01-04 FR FR8400058A patent/FR2557570B1/fr not_active Expired
- 1984-12-26 US US06/686,247 patent/US4629728A/en not_active Expired - Fee Related
-
1985
- 1985-01-03 PT PT79795A patent/PT79795B/pt unknown
- 1985-01-03 GR GR850033A patent/GR850033B/el unknown
- 1985-01-03 CA CA000471438A patent/CA1228359A/fr not_active Expired
- 1985-01-03 AU AU37347/85A patent/AU569208B2/en not_active Ceased
- 1985-01-04 AT AT85400004T patent/ATE43583T1/de active
- 1985-01-04 EP EP85400004A patent/EP0148167B1/de not_active Expired
- 1985-01-04 DE DE8585400004T patent/DE3570658D1/de not_active Expired
- 1985-01-04 ZA ZA8594A patent/ZA8594B/xx unknown
- 1985-01-04 JP JP60000080A patent/JPS60248673A/ja active Granted
- 1985-01-04 OA OA58499A patent/OA07926A/xx unknown
- 1985-01-04 ES ES539373A patent/ES8605796A1/es not_active Expired
- 1985-01-04 IE IE21/85A patent/IE57934B1/en not_active IP Right Cessation
- 1985-01-04 NZ NZ210762A patent/NZ210762A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE850021L (en) | 1985-07-04 |
| ES8605796A1 (es) | 1986-04-01 |
| JPH0344069B2 (de) | 1991-07-04 |
| NZ210762A (en) | 1988-02-29 |
| PT79795B (fr) | 1987-01-07 |
| IE57934B1 (en) | 1993-05-19 |
| FR2557570B1 (fr) | 1986-04-18 |
| PT79795A (fr) | 1985-02-01 |
| US4629728A (en) | 1986-12-16 |
| AU569208B2 (en) | 1988-01-21 |
| OA07926A (fr) | 1987-01-31 |
| EP0148167A3 (en) | 1985-08-28 |
| FR2557570A1 (fr) | 1985-07-05 |
| DE3570658D1 (en) | 1989-07-06 |
| GR850033B (de) | 1985-05-03 |
| ES539373A0 (es) | 1986-04-01 |
| ZA8594B (en) | 1985-08-28 |
| JPS60248673A (ja) | 1985-12-09 |
| AU3734785A (en) | 1985-07-18 |
| CA1228359A (fr) | 1987-10-20 |
| EP0148167A2 (de) | 1985-07-10 |
| EP0148167B1 (de) | 1989-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE40368T1 (de) | Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ES535552A0 (es) | Un procedimiento para la preparacion de nuevos derivados de tiazolidina. | |
| ATE43583T1 (de) | Quinolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel. | |
| ATE117304T1 (de) | Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
| ATE17728T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE74352T1 (de) | Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| ATE15662T1 (de) | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| ATE107298T1 (de) | 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| OA07703A (fr) | Polyméthylène imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant. | |
| ATE112267T1 (de) | Diacylglycerol-nicotinate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ATE101610T1 (de) | Indol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| SE8702119L (sv) | 3-(hydroximetyl)-isokinolinderivat, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande desamma | |
| DE3770117D1 (de) | Neue 1-/ 3-(2-dialkylaminoaethoxy)-2-thienyl/-3-phenyl-1-propanone und ihre saeureadditionssalze und verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DE3862426D1 (de) | 2-selenomethyl-1,4-dihydropyridine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE68903077T2 (de) | Benzopyrrolidinon-derivate, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. | |
| ATE27278T1 (de) | Thieno(2,3-6)pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| DE3680893D1 (de) | Pyrimido(5,4-b)(1,4)oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b)(1,4)oxazinderivate. | |
| DE3778152D1 (de) | Derivate von 5-(2-(1-pyrrolidinyl)-aethoxy)-p-cymen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel. | |
| FR2711651B1 (fr) | Nouveaux analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant. |